Daniel U. Rabin

1.9k total citations
36 papers, 1.6k citations indexed

About

Daniel U. Rabin is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Daniel U. Rabin has authored 36 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 15 papers in Endocrinology, Diabetes and Metabolism and 14 papers in Surgery. Recurrent topics in Daniel U. Rabin's work include Pancreatic function and diabetes (14 papers), Diabetes and associated disorders (9 papers) and Protein Tyrosine Phosphatases (5 papers). Daniel U. Rabin is often cited by papers focused on Pancreatic function and diabetes (14 papers), Diabetes and associated disorders (9 papers) and Protein Tyrosine Phosphatases (5 papers). Daniel U. Rabin collaborates with scholars based in United States, Australia and Germany. Daniel U. Rabin's co-authors include Jeffrey Shapiro, H Yoo-Warren, W. W. Lacy, Naji N. Abumrad, Jean‐Michel Hermel, Michele Solimena, Rebecca Palmer-Crocker, David E. Goldstein, Jessica Hicks and Peter M. M. Rae and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Daniel U. Rabin

36 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel U. Rabin United States 19 706 673 667 540 182 36 1.6k
Thomas Bouckenooghe Belgium 17 811 1.1× 645 1.0× 436 0.7× 502 0.9× 242 1.3× 28 1.9k
Diane Ostrega United States 16 847 1.2× 490 0.7× 472 0.7× 601 1.1× 38 0.2× 19 1.4k
Loredana Farilla United States 14 936 1.3× 460 0.7× 1.0k 1.5× 793 1.5× 121 0.7× 22 2.0k
Blair E. Cox United States 18 361 0.5× 182 0.3× 451 0.7× 366 0.7× 171 0.9× 22 1.5k
Mark Lipsett Canada 16 620 0.9× 476 0.7× 483 0.7× 281 0.5× 46 0.3× 19 1.0k
A A Like United States 15 740 1.0× 877 1.3× 603 0.9× 244 0.5× 323 1.8× 16 1.4k
Hiroko Kadowaki Japan 21 604 0.9× 348 0.5× 440 0.7× 1.5k 2.8× 28 0.2× 63 2.1k
Joyce F. Haskell United States 18 210 0.3× 263 0.4× 651 1.0× 626 1.2× 45 0.2× 26 1.3k
Jianqing Zhou China 21 153 0.2× 285 0.4× 452 0.7× 729 1.4× 126 0.7× 59 1.6k
Brenda Strutt Canada 17 663 0.9× 421 0.6× 459 0.7× 420 0.8× 51 0.3× 27 1.2k

Countries citing papers authored by Daniel U. Rabin

Since Specialization
Citations

This map shows the geographic impact of Daniel U. Rabin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel U. Rabin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel U. Rabin more than expected).

Fields of papers citing papers by Daniel U. Rabin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel U. Rabin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel U. Rabin. The network helps show where Daniel U. Rabin may publish in the future.

Co-authorship network of co-authors of Daniel U. Rabin

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel U. Rabin. A scholar is included among the top collaborators of Daniel U. Rabin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel U. Rabin. Daniel U. Rabin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rabin, Daniel U., et al.. (2017). Extended-Release and Long-Acting Opioid Analgesics Risk Evaluation and Mitigation Strategy (REMS):. Journal of Medical Regulation. 103(4). 7–16. 10 indexed citations
2.
Hicks, Charles B., Susanna Naggie, David A. Wohl, et al.. (2014). VISION: A Regional Performance Improvement Initiative for HIV Health Care Providers. Journal of Continuing Education in the Health Professions. 34(3). 171–178. 2 indexed citations
3.
Mayrhofer, Markus, Daniel U. Rabin, Louisa A. Messenger, Eberhard Standl, & Anette‐Gabriele Ziegler. (2009). Value of ICA512 antibodies for prediction and diagnosis of type 1 diabetes. Experimental and Clinical Endocrinology & Diabetes. 104(3). 228–234. 2 indexed citations
4.
Scriabine, Alexander & Daniel U. Rabin. (2009). New Developments in the Therapy of Pulmonary Fibrosis. Advances in pharmacology. 57. 419–464. 11 indexed citations
5.
Fida, S., Merrill J. Rowley, Lauren Grace Mackey, et al.. (2001). Antibodies to SOX13 (ICA12) are Associated with Type 1 Diabetes. Autoimmunity. 33(2). 95–101. 10 indexed citations
6.
Leiter, Edward H., Hideki Tsumura, David Serreze, et al.. (1997). Mapping to Chromosomes 1 and 12 of mouse homologs of human protein tyrosine phosphatase, receptor-type, related genes encoding pancreatic beta cell autoantigens. Mammalian Genome. 8(12). 949–950. 6 indexed citations
7.
Roggenbuck, Dirk, Jean‐Michel Hermel, Daniel U. Rabin, & Michele Solimena. (1997). ICA 512, a Receptor Tyrosine Phosphatase-Like Protein, Is Concentrated in Neurosecretory Granule Membranes. Advances in pharmacology. 42. 243–246. 16 indexed citations
8.
Zhu, Jian, et al.. (1996). Insulin Signaling in Mice Expressing Reduced Levels of Syp. Journal of Biological Chemistry. 271(35). 21353–21358. 79 indexed citations
9.
Solimena, Michele, Ronald Dirkx, Jean‐Michel Hermel, et al.. (1996). ICA 512, an autoantigen of type I diabetes, is an intrinsic membrane protein of neurosecretory granules.. The EMBO Journal. 15(9). 2102–2114. 209 indexed citations
10.
Tanizawa, Yukio, Minoru Aoki, Jon Wasson, et al.. (1995). Characterization of the LIM/Homeodomain Gene Islet-1 and Single Nucleotide Screening in NIDDM. Diabetes. 44(6). 689–694. 7 indexed citations
11.
Buggy, Joseph J., James N. Livingston, Daniel U. Rabin, & H Yoo-Warren. (1995). Glucagon·Glucagon-like Peptide I Receptor Chimeras Reveal Domains That Determine Specificity of Glucagon Binding. Journal of Biological Chemistry. 270(13). 7474–7478. 52 indexed citations
12.
Rabin, Daniel U., Jeffrey Shapiro, H Yoo-Warren, et al.. (1994). Islet cell antigen 512 is a diabetes-specific islet autoantigen related to protein tyrosine phosphatases.. The Journal of Immunology. 152(6). 3183–3188. 255 indexed citations
13.
Rabin, Daniel U., et al.. (1992). An ELISA sandwich capture assay for recombinant fusion proteins containing glutathione-S-transferase. Journal of Immunological Methods. 156(1). 101–105. 7 indexed citations
14.
Rabin, Daniel U., et al.. (1992). Cloning and expression of IDDM-specific human autoantigens. Diabetes. 41(2). 183–186. 33 indexed citations
15.
Korányi, László, Yukio Tanizawa, Cris M. Welling, Daniel U. Rabin, & M. Alan Permutt. (1992). Human Islet Glucokinase Gene: Isolation and Sequence Analysis of Full-Length cDNA. Diabetes. 41(7). 807–811. 36 indexed citations
16.
Rabin, Daniel U. & Nanibhushan Dattagupta. (1987). A simple DNA diagnostic method for human genetic disorders. Human Genetics. 75(2). 120–122. 7 indexed citations
17.
Doelle, Gregory C., Ronald M. Evans, Andrew L. Alexander, et al.. (1986). Single Dose Responses to the Gonadotropin-Releasing Hormone Agonist Analogue [(imBz1)-D-His6,Pro9-NEt]GnRH. Hormone and Metabolic Research. 18(3). 201–202. 4 indexed citations
18.
Wells, Peter G., G. W. K. Moore, Daniel U. Rabin, et al.. (1980). Metabolic effects and pharmacokinetics of intravenously administered dichloroacetate in humans. Diabetologia. 19(2). 109–113. 81 indexed citations
19.
Rabin, Daniel U.. (1975). The syndromes of isolated gonadotropin deficiency.. PubMed. 11(4). 73–80. 3 indexed citations
20.
Starfield, Bárbara, et al.. (1971). Medical resources and medical education. Academic Medicine. 46(5). 419–30. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Thomas Bouckenooghe Breakdown of academic impact, for papers by Diane Ostrega Breakdown of academic impact, for papers by Loredana Farilla Breakdown of academic impact, for papers by Blair E. Cox Breakdown of academic impact, for papers by Mark Lipsett Breakdown of academic impact, for papers by A A Like Breakdown of academic impact, for papers by Hiroko Kadowaki Breakdown of academic impact, for papers by Joyce F. Haskell Breakdown of academic impact, for papers by Jianqing Zhou Breakdown of academic impact, for papers by Brenda Strutt
Rankless by CCL
2026